Posted: 18 November 2022
The 2022 BioMelbourne Network Annual General Meeting and Networking Event was held on Thursday 17 November in person and online.
Honorary Life Membership awards
BioMelbourne Network bestows Honorary Life Membership awards to Members whose service has provided significant benefit to the Network.
At the 2022 AGM, we honoured two outstanding Members whose commitment over many years has supported the healthtech industry and progressed BioMelbourne Network’s strategic objectives.
Honorary Life Membership: Dr Amanda Caples
Dr Amanda Caples is Victoria’s Lead Scientist. She has extensive experience in technology commercialisation, public policy development and governance of public and private entities.
Amanda is a Director of Breakthrough Victoria Pty Ltd; Chair of mRNA Victoria’s Scientific Advisory Group; Director of Agriculture Victoria Services Pty Ltd; a member of the Rail Industry Development Advisory Committee and Chair of the Victorian Quantum Technology Network, which advances teaching and research in quantum technologies.
She also plays a significant role in non-government Boards and advisory bodies, including: RMIT Space Industry Hub; Ivanhoe Grammar School (Deputy Chair); Swinburne Industry Research Advisory Committee; STEM Sisters and Springboard Enterprises Life Science Council.
Amanda has led the development of industry, science and innovation policy in Victoria since joining the Victorian Public Service in 2002 as the inaugural Director of Biotechnology. During this time, she has delivered major policy reforms, a range of programs, global partnerships and landmark initiatives, including the Victorian Comprehensive Cancer Centre.
Honorary Life Membership: Lusia Guthrie
Lusia Guthrie was appointed to the BioMelbourne Network Board Member in 2017, becoming Deputy Chair from 2017 to 2018 and Chair from 2018 to 2021. She was also acting CEO from December 2016 to April 2017 and March to June 2020.
Lusia is a company director, entrepreneur, founder and CEO, with over 35 years’ experience in the healthtech and biotech sectors in clinical pathology, pharmaceutical manufacturing, and medtech product development and commercialisation.
Lusia has actively led and supported the growth of the healthtech sector in Victoria and Australia, and is influential nationally and globally. She brings academia, government, industry and not-for-profits together to drive growth, change and medical innovation.
Lusia is also a mentor to future leaders in industry and academia, extending her impact for years to come.
Outgoing Secretary and Public Officer: Amy Demediuk
Amy Demediuk retired from her roles as Secretary and Public Officer of the BioMelbourne Network Board of Directors at the 2022 Annual General Meeting on 17 November.
At the AGM, BioMelbourne Network thanked Amy for her direct involvement, strong and effective leadership, and clear direction to the Board and CEO Jeff Malone.
As Chair of the Nominations and Remuneration Committee, Amy has taken the lead to ensure that BioMelbourne Network could seek her replacement.
Incoming Secretary and Public Officer: Stefanie Mackenzie
BioMelbourne Network is pleased to announce the appointment of Stefanie Mackenzie as Secretary and Public Officer of the BioMelbourne Network Board of Directors at the 2022 Annual General Meeting on 17 November.
Read Stefanie’s biography here
Re-elected Chair: David Herd
BioMelbourne Network is pleased to announce the re-election for a second term of David Herd as Chair of the BioMelbourne Network Board of Directors at the 2022 Annual General Meeting on 17 November.
Re-elected Treasurer: Theodora Elia Adams
BioMelbourne Network is pleased to announce the re-election for a second term of Theodora Elia-Adams as Treasurer of the BioMelbourne Network Board of Directors at the 2022 Annual General Meeting on 17 November.
Read Theodora’s biography here
Re-elected Director: Dr Keith McLean
BioMelbourne Network is pleased to announce the re-election for a second term of Dr Keith McLean as Director of the BioMelbourne Network Board at the 2022 Annual General Meeting on 17 November.
Ratification of Nominated Member: Dr Tim Oldham
BioMelbourne Network is pleased to announce the ratification of Dr Tim Oldham for a third term as Director of the BioMelbourne Network Board at the 2022 Annual General Meeting on 17 November.
Ratification of Nominated Member: Andrew Wear
BioMelbourne Network is pleased to announce the ratification of Andrew Wear for his first term as Director of the BioMelbourne Network Board at the 2022 Annual General Meeting on 17 November.
BioMelbourne Network: 2022 Annual Report
